CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 16:00
CureVac 1 Year Total Returns (Daily) : 9.13% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 9.13% |
| June 09, 2026 | 4.02% |
| June 08, 2026 | 5.67% |
| June 05, 2026 | 4.48% |
| June 04, 2026 | 4.96% |
| June 03, 2026 | -0.85% |
| June 02, 2026 | 0.65% |
| June 01, 2026 | 4.25% |
| May 29, 2026 | 0.65% |
| May 28, 2026 | 4.96% |
| May 27, 2026 | 7.13% |
| May 26, 2026 | 13.94% |
| May 22, 2026 | 12.02% |
| May 21, 2026 | 19.49% |
| May 20, 2026 | 8.88% |
| May 19, 2026 | 20.41% |
| May 18, 2026 | 25.27% |
| May 15, 2026 | 36.06% |
| May 14, 2026 | 38.28% |
| May 13, 2026 | 37.26% |
| May 12, 2026 | 28.73% |
| May 11, 2026 | 34.29% |
| May 08, 2026 | 29.80% |
| May 07, 2026 | 34.29% |
| May 06, 2026 | 38.69% |
| Date | Value |
|---|---|
| May 05, 2026 | 34.29% |
| May 04, 2026 | 30.90% |
| May 01, 2026 | 37.06% |
| April 30, 2026 | 31.27% |
| April 29, 2026 | 32.01% |
| April 28, 2026 | 34.29% |
| April 27, 2026 | 44.27% |
| April 24, 2026 | 42.94% |
| April 23, 2026 | 47.00% |
| April 22, 2026 | 46.08% |
| April 21, 2026 | 45.17% |
| April 20, 2026 | 49.36% |
| April 17, 2026 | 49.36% |
| April 16, 2026 | 45.62% |
| April 15, 2026 | 44.27% |
| April 14, 2026 | 42.51% |
| April 13, 2026 | 46.08% |
| April 10, 2026 | 62.94% |
| April 09, 2026 | 56.38% |
| April 08, 2026 | 71.32% |
| April 07, 2026 | 75.85% |
| April 06, 2026 | 79.92% |
| April 02, 2026 | 62.94% |
| April 01, 2026 | 71.32% |
| March 31, 2026 | 68.23% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| PAION AG | 0.00% |
| Epigenomics AG | 41.84% |
| ACADIA Pharmaceuticals, Inc. | -4.28% |
| Alkermes Plc | 41.15% |
| Alnylam Pharmaceuticals, Inc. | -3.72% |